SCHEMBL6137586

SCHEMBL6137586

O=C1Nc2cc(CCCO)ccc2C2CCCC12

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.34
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
PDE3B Q13370 2/20 0.34
PDE3A Q14432 2/20 0.34
P2RY12 Q9H244 2/20 0.34
CHEK1 O14757 3/20 0.34
MAP2K1 Q02750 1/20 0.32
CYP4A11 Q02928 2/20 0.32
CYP4F2 P78329 1/20 0.32
NOS3 P29474 2/20 0.31
NOS1 P29475 2/20 0.31
NOS2 P35228 2/20 0.31
CA2 P00918 1/20 0.31
BCHE P06276 1/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6069811 0.92 PARP1 (0.35) PARP1TNKSTNKS2CHEK1MAP2K1
SCHEMBL6069563 0.86 DDB1 (0.39) PARP1TNKSTNKS2CHEK1MAP2K1
SCHEMBL6137668 0.83 FFAR4 (0.39)
SCHEMBL6070036 0.79 FKBP1A (0.35) PARP1TNKSTNKS2PDE3BPDE3A
SCHEMBL6069805 0.79 HRH3 (0.40)
SCHEMBL6137379 0.77 DUT (0.35) PARP1TNKSTNKS2
SCHEMBL6137343 0.74 TNKS (0.33) PARP1TNKSTNKS2
SCHEMBL6642433 0.73 NOS3 (0.44) PARP1NOS3NOS1NOS2
SCHEMBL6645276 0.73 NOS3 (0.44) NOS3NOS1NOS2
SCHEMBL6069583 0.73 FFAR1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed